Acrospire Investment Management LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2017$39,000
-15.2%
2,258
-45.7%
0.04%
-2.6%
Q1 2017$46,000
-72.8%
4,158
-64.3%
0.04%
-45.7%
Q4 2016$169,000
-47.8%
11,658
-11.7%
0.07%
-67.4%
Q3 2016$324,000
+390.9%
13,200
+300.0%
0.22%
+338.8%
Q2 2016$66,000
-38.9%
3,300
-19.5%
0.05%
-34.7%
Q1 2016$108,0004,1000.08%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2017
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders